{"filing":{"accession_number":"0001376339-26-000070","cik":"0001376339","ticker":"MDXG","company_name":"MIMEDX GROUP, INC.","form":"8-K","filing_date":"2026-07-29","report_date":"2026-07-29","primary_document":"mdxg-20260729.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633926000070/mdxg-20260729.htm"},"events":[{"id":21576,"run_id":19463,"accession_number":"0001376339-26-000070","anchor_item_number":"1.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.99,"summary":"MiMedx entered into a definitive Agreement and Plan of Merger to acquire all outstanding shares of Sanara MedTech for $35 per share in a cash-and-stock transaction valued at approximately $350 million enterprise value. The transaction, unanimously approved by both boards and backed by $300 million in committed debt financing, is expected to close by year-end 2026 subject to Sanara shareholder approval and regulatory clearance, and is described as a transformational combination that will nearly double surgical revenue.","company_name":"MIMEDX GROUP, INC.","ticker":"MDXG","filing_date":"2026-07-29","form":"8-K","submitted_at":null,"items":[{"id":21247,"accession_number":"0001376339-26-000070","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.99,"reasoning":"MiMedx entered into a definitive Agreement and Plan of Merger with Sanara MedTech on July 29, 2026, under which MiMedx will acquire all outstanding shares of Sanara in a cash-and-stock transaction valued at approximately $350 million enterprise value ($35 per share). This is a material acquisition meeting the Item 1.01 standard, with both boards unanimously approving the transaction, committed debt financing of $300 million, and expected closing by year-end subject to customary conditions including Sanara shareholder approval and regulatory clearance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-29T20:05:58.064423+00:00","company_name":"","ticker":null,"filing_date":""},{"id":21248,"accession_number":"0001376339-26-000070","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.99,"reasoning":"MiMedx announced entry into a definitive merger agreement to acquire Sanara MedTech for $35 per share ($350 million enterprise value) in a cash-and-stock transaction. The press release explicitly states \"MIMEDX will acquire all of the outstanding shares of Sanara\" and describes this as a \"transformational combination\" that \"nearly doubles surgical revenue\" with expected 2027 combined revenue exceeding $400 million. This is a material acquisition requiring shareholder approval and regulatory clearance, expected to close by year-end 2026.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-29T20:05:58.064423+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":21247,"accession_number":"0001376339-26-000070","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.99,"reasoning":"MiMedx entered into a definitive Agreement and Plan of Merger with Sanara MedTech on July 29, 2026, under which MiMedx will acquire all outstanding shares of Sanara in a cash-and-stock transaction valued at approximately $350 million enterprise value ($35 per share). This is a material acquisition meeting the Item 1.01 standard, with both boards unanimously approving the transaction, committed debt financing of $300 million, and expected closing by year-end subject to customary conditions including Sanara shareholder approval and regulatory clearance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-29T20:05:58.064423+00:00","company_name":"MIMEDX GROUP, INC.","ticker":"MDXG","filing_date":"2026-07-29"},{"id":21248,"accession_number":"0001376339-26-000070","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.99,"reasoning":"MiMedx announced entry into a definitive merger agreement to acquire Sanara MedTech for $35 per share ($350 million enterprise value) in a cash-and-stock transaction. The press release explicitly states \"MIMEDX will acquire all of the outstanding shares of Sanara\" and describes this as a \"transformational combination\" that \"nearly doubles surgical revenue\" with expected 2027 combined revenue exceeding $400 million. This is a material acquisition requiring shareholder approval and regulatory clearance, expected to close by year-end 2026.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-29T20:05:58.064423+00:00","company_name":"MIMEDX GROUP, INC.","ticker":"MDXG","filing_date":"2026-07-29"}]}